The Kv7 potassium channel activator retigabine decreases alcohol consumption in rats

Author： Knapp Clifford M.   O’Malley Matthew   Datta Subimal   Ciraulo Domenic A.  

Publisher： Informa Healthcare

ISSN： 0095-2990

Source： The American Journal of Drug and Alcohol Abuse, Vol.40, Iss.3, 2014-05, pp. : 244-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Retigabine/Ezogabine, a KCNQ/KV7 channel opener: pharmacological and clinical data

By Orhan Gökce   Wuttke Thomas V   Nies Anne T   Schwab Matthias   Lerche Holger  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1807-1816

Informa Healthcare

Access to resources Recommend Favorite

Anti-Ulcer Activity of Skp-450, a Novel Potassium Channel Activator, in Rats

By Cheon H.G.Y.E.O.N.G.   Kim H.J.U.N.G.   Mo H.K.Y.O.U.N.G.   Yoo S.E.U.N.   Lee B.H.O.  

Pharmacological Research, Vol. 40, Iss. 3, 1999-09 ,pp. : 243-248

Academic Press

Access to resources Recommend Favorite

The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation

By Dost R.   Rostock A.   Rundfeldt C.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 4, 2004-04 ,pp. : 382-390

Springer Publishing Company

Access to resources Recommend Favorite

Drug Discoveries Towards Kv1.5 Potassium Channel

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-03 ,pp. : 339-347

Bentham Science Publishers

Access to resources Recommend Favorite

Kv7 Channels: Function, Pharmacology and Channel Modulators

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-05 ,pp. : 999-1023

Bentham Science Publishers

Access to resources Recommend Favorite